AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25179753 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Intervention with Telephone Boosters (BI-B)
Number of subjects: 1285
Study 25179753 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening, Assessment, and Referral to Treatment (SAR)
Number of subjects: 1285
Study 25179753 — intervention group
Group type: COMPARATOR
Intervention: Minimal Screening Only (MSO)
Number of subjects: 1285
Study 22907053 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilatory response to hypoxia in men
Number of subjects: 4675
Study 22907053 — intervention group
Group type: EXPERIMENTAL
Intervention: Desaturation response to hypoxia in men
Number of subjects: 4675
Study 22907053 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac response to hypoxia
Number of subjects: 4675
Study 22907053 — intervention group
Group type: EXPERIMENTAL
Intervention: Desaturation response at exercise in trained subjects
Number of subjects: 4675
Study 22907053 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac response in post-menopausal women
Number of subjects: 4675
Study 20041428 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical (0.5%) Pycnogenol and oral Pycnogenol
Number of subjects: 84
Study 20041428 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral and topical Pycnogenol
Number of subjects: 84
Study 20041428 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 84
Study 20041428 — intervention group
Group type: EXPERIMENTAL
Intervention: Pycnogenol (oral and topical)
Number of subjects: 84
Study 18318105 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilisation exercise training
Number of subjects: 22
Study 18318105 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 22
Study 16362714 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolmitriptan nasal spray
Number of subjects: 851
Study 12222660 — intervention group
Group type: EXPERIMENTAL
Intervention: PYCNOGENOL chewing gums (5 mg)
Number of subjects: 40
Study 12222660 — intervention group
Group type: COMPARATOR
Intervention: Control gums without PYCNOGENOL
Number of subjects: 40
Study 10381531 — intervention group
Group type: EXPERIMENTAL
Intervention: SCF + G-CSF
Number of subjects: 203
Study 10381531 — intervention group
Group type: COMPARATOR
Intervention: G-CSF
Number of subjects: 203
Study 10381531 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF + SCF
Number of subjects: 203
Study 7721419 — intervention group
Group type: EXPERIMENTAL
Intervention: cilazapril
Number of subjects: 17
Study 7721419 — intervention group
Group type: COMPARATOR
Intervention: atenolol
Number of subjects: 17
Study 10145317 — intervention group
Group type: EXPERIMENTAL
Intervention: One hand ventilation
Number of subjects: 24
Study 10145317 — intervention group
Group type: EXPERIMENTAL
Intervention: Two hands ventilation
Number of subjects: 24
Study 10145317 — intervention group
Group type: EXPERIMENTAL
Intervention: Small hands
Number of subjects: 24
Study 10145317 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium hands
Number of subjects: 24
Study 10145317 — intervention group
Group type: EXPERIMENTAL
Intervention: Large hands
Number of subjects: 24
Study 10145317 — intervention group
Group type: EXPERIMENTAL
Intervention: Gloves
Number of subjects: 24
Study 10145317 — intervention group
Group type: COMPARATOR
Intervention: No gloves
Number of subjects: 24
Study 10145317 — intervention group
Group type: EXPERIMENTAL
Intervention: Code Blue resuscitator
Number of subjects: 24
Study 10145317 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospitak resuscitator
Number of subjects: 24
Study 10145317 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmanex resuscitator
Number of subjects: 24
Study 10145317 — intervention group
Group type: EXPERIMENTAL
Intervention: Mercury resuscitator
Number of subjects: 24
Study 10145317 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambu SPUR resuscitator
Number of subjects: 24
Study 6113174 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketazolam
Number of subjects: 95
Study 6113174 — intervention group
Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 95
Study 30701655 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment stimulation (peripheral nerve stimulation)
Number of subjects: 77
Study 30701655 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 77
Study 28210811 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral health care training (IG)
Number of subjects: 81
Study 28210811 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention group (non-IG)
Number of subjects: 81
Study 28210811 — intervention group
Group type: COMPARATOR
Intervention: DC group (control)
Number of subjects: 81
Study 25471234 — intervention group
Group type: EXPERIMENTAL
Intervention: ARB plus CCB therapy (olmesartan 20 mg per day)
Number of subjects: 1078
Study 25471234 — intervention group
Group type: COMPARATOR
Intervention: High-dose ARB therapy (olmesartan 40 mg per day)
Number of subjects: 1078
Study 23589779 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine (2 mg) + Desmopressin (20 μg)
Number of subjects: 100
Study 23589779 — intervention group
Group type: COMPARATOR
Intervention: Desmopressin (20 μg) + placebo
Number of subjects: 100
Study 21403136 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulb syringe self-irrigation with ear drops and instructions
Number of subjects: 237
Study 21403136 — intervention group
Group type: COMPARATOR
Intervention: Routine care (ear drops followed by clinic irrigation)
Number of subjects: 237
Study 21403136 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulb syringe self-irrigation
Number of subjects: 237
Study 21403136 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 237
Study 19522897 — intervention group
Group type: EXPERIMENTAL
Intervention: Shellac F
Number of subjects: 10
Study 19522897 — intervention group
Group type: COMPARATOR
Intervention: Duraphat
Number of subjects: 10
Study 19522897 — intervention group
Group type: COMPARATOR
Intervention: Isodan
Number of subjects: 10
Study 19122245 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass surgery (CABG)
Number of subjects: 0
Study 19122245 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 0
Study 19122245 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive management including early revascularization and potent platelet inhibition
Number of subjects: 0
Study 15238022 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard condition requiring study for a later memory test
Number of subjects: 0
Study 15238022 — intervention group
Group type: EXPERIMENTAL
Intervention: Condition requiring a judgment about unusual letters
Number of subjects: 0
Study 15238022 — intervention group
Group type: COMPARATOR
Intervention: Low-frequency words (LF)
Number of subjects: 0
Study 15238022 — intervention group
Group type: COMPARATOR
Intervention: High-frequency words (HF)
Number of subjects: 0
Study 11985186 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-minute music-based intervention in a preoperative holding area
Number of subjects: 20
Study 11985186 — intervention group
Group type: COMPARATOR
Intervention: Customary preoperative care
Number of subjects: 20
Study 9779099 — intervention group
Group type: EXPERIMENTAL
Intervention: Etched (phosphoric acid gel)
Number of subjects: 30
Study 9779099 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonded (Scotchbond MP)
Number of subjects: 30
Study 9779099 — intervention group
Group type: COMPARATOR
Intervention: Smeared (control)
Number of subjects: 30
Study 9779099 — intervention group
Group type: EXPERIMENTAL
Intervention: Cementation with zinc phosphate cement at 100N
Number of subjects: 30
Study 7768655 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 weeks immobilisation in a plaster splint
Number of subjects: 33
Study 7768655 — intervention group
Group type: COMPARATOR
Intervention: 5 weeks immobilisation in a plaster splint
Number of subjects: 33
Study 2698272 — intervention group
Group type: EXPERIMENTAL
Intervention: Amineptine (100-200 mg per day)
Number of subjects: 33
Study 2698272 — intervention group
Group type: COMPARATOR
Intervention: Imipramine (50-100 mg per day)
Number of subjects: 33
Study 2698272 — intervention group
Group type: EXPERIMENTAL
Intervention: Amineptine
Number of subjects: 33
Study 2698272 — intervention group
Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 33
Study 776441 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanethidine
Number of subjects: 49
Study 776441 — intervention group
Group type: COMPARATOR
Intervention: Reserpine
Number of subjects: 49
Study 31084971 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative ketamine infusion at a rate of 6 mcg/kg/min for 75 minutes
Number of subjects: 91
Study 31084971 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative ketamine infusion
Number of subjects: 91
Study 31084971 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 91
Study 27823944 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical lidocaine-prilocaine (LP) cream
Number of subjects: 120
Study 27823944 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 26123101 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine milk containing antibodies
Number of subjects: 61
Study 26123101 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 23731768 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD3199 (200, 400 or 800 μg o.d.)
Number of subjects: 329
Study 23731768 — intervention group
Group type: COMPARATOR
Intervention: Formoterol (9 μg b.i.d.)
Number of subjects: 329
Study 23731768 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 329
Study 21411606 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (20,000 IU for < 12 mo; 45,000 IU for ≥ 12 mo)
Number of subjects: 127
Study 21411606 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 127
Study 21411606 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study 19268410 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus (0.1 to 0.2 mg/kg/d)
Number of subjects: 41
Study 19268410 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine (5 to 6 mg/kg/d)
Number of subjects: 41
Study 19268410 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 41
Study 19268410 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 41
Study 17879570 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 U BTX‐A injected endoscopically into the antrum and the distal gastric body
Number of subjects: 10
Study 17879570 — intervention group
Group type: COMPARATOR
Intervention: 0.9% Saline injected endoscopically into the antrum and the distal gastric body
Number of subjects: 10
Study 16036031 — intervention group
Group type: EXPERIMENTAL
Intervention: Drugs that modulate the renin-angiotensin and sympathetic nervous systems
Number of subjects: 0
Study 16036031 — intervention group
Group type: EXPERIMENTAL
Intervention: Redirected therapy to prevent and treat sudden death
Number of subjects: 0
Study 11598428 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 65
Study 11598428 — intervention group
Group type: COMPARATOR
Intervention: Behavior Therapy (BT)
Number of subjects: 65
Study 9477980 — intervention group
Group type: COMPARATOR
Intervention: Deferral of photocoagulation in eyes assigned to the Early Treatment Diabetic Retinopathy Study (ETDRS)
Number of subjects: 0
Study 8163257 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical felbinac
Number of subjects: 0
Study 8163257 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8163257 — intervention group
Group type: COMPARATOR
Intervention: Piroxicam
Number of subjects: 0
Study 3673206 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 micrograms of Pasteur's hepatitis B vaccine
Number of subjects: 300
Study 3673206 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 micrograms of Pasteur's hepatitis B vaccine
Number of subjects: 300
Study 3673206 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 microgram of Pasteur's hepatitis B vaccine
Number of subjects: 300
Study 30686266 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus buchneri strains (56.1, 56.4, 56.9, 56.26, and commercial inoculant 'Lalsil Cana')
Number of subjects: 4
Study 30686266 — intervention group
Group type: COMPARATOR
Intervention: Control (without inoculation)
Number of subjects: 4
Study 29092761 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-driven targeted HIV screening alongside physician-directed diagnostic testing
Number of subjects: 148327
Study 29092761 — intervention group
Group type: COMPARATOR
Intervention: Diagnostic testing alone
Number of subjects: 148327
Study 27369430 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin (first taste)
Number of subjects: 46
Study 27369430 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin (second taste)
Number of subjects: 46
Study 27369430 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin Rising
Number of subjects: 46
Study 27369430 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin Perrigo
Number of subjects: 46
Study 27369430 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin Greenstone
Number of subjects: 46
Study 27369430 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen elixir
Number of subjects: 46
Study 27369430 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen suspension
Number of subjects: 46
Study 26273191 — intervention group
Group type: EXPERIMENTAL
Intervention: Torasemide-PR 10 mg
Number of subjects: 10
Study 26273191 — intervention group
Group type: COMPARATOR
Intervention: Furosemide-IR 40 mg
Number of subjects: 10
Study 23207882 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal strength training (MST)
Number of subjects: 16
Study 23207882 — intervention group
Group type: COMPARATOR
Intervention: Resistance training
Number of subjects: 16
Study 23207882 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study 21669380 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher hemoglobin (Hgb) levels
Number of subjects: 0
Study 21669380 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss of 2 g/dl Hgb or more
Number of subjects: 0
Study 21669380 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower levels of Hgb
Number of subjects: 0
Study 19358959 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus adjunctive care by a homeopath
Number of subjects: 47
Study 19358959 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 47
Study 16473984 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram + Methylphenidate (CIT + MPH)
Number of subjects: 16
Study 16473984 — intervention group
Group type: COMPARATOR
Intervention: Citalopram + Placebo (CIT + PBO)
Number of subjects: 16
Study 12740264 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol (80 micro g/4.5 micro g, bid)
Number of subjects: 467
Study 12740264 — intervention group
Group type: COMPARATOR
Intervention: Budesonide (200 micro g, bid)
Number of subjects: 467
Study 10692524 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuprammonium (CU) dialyser
Number of subjects: 11
Study 10692524 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuprammonium (CU) dialyser with dialysate filter (CUf)
Number of subjects: 11
Study 10692524 — intervention group
Group type: COMPARATOR
Intervention: Polysulphon (PS) dialyser
Number of subjects: 11
Study 10692524 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuprammonium (CU) and CUf
Number of subjects: 11
Study 10692524 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuprammonium (CU)
Number of subjects: 11
Study 9179687 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative endocrine therapy (leuprolide and chlormadinone for 3 months)
Number of subjects: 224
Study 1422972 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral phosphate 1500 mg/day
Number of subjects: 82
Study 1422972 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral phosphate 2250 mg/day
Number of subjects: 82
Study 1422972 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral phosphate 750 mg/day
Number of subjects: 82
Study 1422972 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 3972658 — intervention group
Group type: EXPERIMENTAL
Intervention: 252Cf implants alone (Group I)
Number of subjects: 47
Study 3972658 — intervention group
Group type: EXPERIMENTAL
Intervention: 252Cf implants in combination with external radiation (Group II)
Number of subjects: 47
Study 3972658 — intervention group
Group type: EXPERIMENTAL
Intervention: Interstitial implants for recurrent or residual tumors (Group III)
Number of subjects: 47
Study 31737925 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A - Patients explained the importance of frequency volume charts by a doctor and then a nurse explained how to fill it.
Number of subjects: 137
Study 31737925 — intervention group
Group type: COMPARATOR
Intervention: Group B - Patients were only explained how to fill it.
Number of subjects: 137
Study 31737925 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A - Patients explained the importance of frequency volume charts.
Number of subjects: 137
Study 31737925 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients aged 60's years old (vs 50's years).
Number of subjects: 137
Study 30777509 — intervention group
Group type: EXPERIMENTAL
Intervention: Task switching during encoding
Number of subjects: 0
Study 30777509 — intervention group
Group type: EXPERIMENTAL
Intervention: Task switching with bivalent material (Experiment 2)
Number of subjects: 0
Study 30305170 — intervention group
Group type: EXPERIMENTAL
Intervention: High media multitaskers
Number of subjects: 0
Study 30305170 — intervention group
Group type: EXPERIMENTAL
Intervention: Relevant environmental cues
Number of subjects: 0
Study 30305170 — intervention group
Group type: COMPARATOR
Intervention: Irrelevant cue condition
Number of subjects: 0
Study 27061508 — intervention group
Group type: EXPERIMENTAL
Intervention: SOLE VLBWI Questionnaire
Number of subjects: 152
Study 27061508 — intervention group
Group type: COMPARATOR
Intervention: PedsQL
Number of subjects: 152
Study 24607301 — intervention group
Group type: EXPERIMENTAL
Intervention: RESMENA diet (30% energy from protein)
Number of subjects: 96
Study 24607301 — intervention group
Group type: COMPARATOR
Intervention: Control diet (15% energy from protein)
Number of subjects: 96
Study 24607301 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-protein group (RESMENA diet)
Number of subjects: 96
Study 24607301 — intervention group
Group type: EXPERIMENTAL
Intervention: Total protein intake
Number of subjects: 96
Study 24607301 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal protein
Number of subjects: 96
Study 24607301 — intervention group
Group type: EXPERIMENTAL
Intervention: Meat protein
Number of subjects: 96
Study 24607301 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetable- and fish-derived proteins
Number of subjects: 96
Study 22952756 — intervention group
Group type: EXPERIMENTAL
Intervention: ART cessation in primary HIV infection (PHI)
Number of subjects: 1632
Study 22952756 — intervention group
Group type: COMPARATOR
Intervention: ART cessation in chronic HIV infection (CHI)
Number of subjects: 1632
Study 22952756 — intervention group
Group type: COMPARATOR
Intervention: ART cessation in chronic HIV infection (CHI) with CD4 nadir >500 cells/mm(3)
Number of subjects: 1632
Study 19085099 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragm, lubricant gel, and condoms
Number of subjects: 5039
Study 19085099 — intervention group
Group type: COMPARATOR
Intervention: Condoms alone
Number of subjects: 5039
Study 19085099 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragm only
Number of subjects: 5039
Study 19085099 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragm instead of condom
Number of subjects: 5039
Study 17461317 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch (HES)
Number of subjects: 45
Study 17461317 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% human albumin (HA)
Number of subjects: 45
Study 17461317 — intervention group
Group type: COMPARATOR
Intervention: 4% succinylated gelatin (GEL)
Number of subjects: 45
Study 15201093 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy with concurrent chemotherapy (Group A): leucovorin (CF, 100 mg/m(2), days 1‐5), 5‐fluorouracil (5‐Fu, 500 mg/m(2), days 1‐5), cisplatin (DDP, 60 mg/m(2), day 1) for one course followed by another 4 weeks later.
Number of subjects: 80
Study 15201093 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy with concurrent chemotherapy (Group A)
Number of subjects: 80
Study 15201093 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone (Group B)
Number of subjects: 80
Study 11693978 — intervention group
Group type: EXPERIMENTAL
Intervention: Organized or opportunistic cytology screening programmes
Number of subjects: 0
Study 11693978 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted screening on high-risk women
Number of subjects: 0
Study 11693978 — intervention group
Group type: EXPERIMENTAL
Intervention: Reorganizing screening programmes in middle-income countries
Number of subjects: 0
Study 9688993 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased physical activity
Number of subjects: 38
Study 9688993 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 38
Study 7862941 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.25 mg
Number of subjects: 23
Study 7862941 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.50 mg
Number of subjects: 23
Study 7862941 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 23
Study 7862941 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 20 mg
Number of subjects: 23
Study 7862941 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 2514430 — intervention group
Group type: EXPERIMENTAL
Intervention: Taprostene (25 ng/kg/min intravenously for 6 hours daily on 5 consecutive days)
Number of subjects: 30
Study 2514430 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 126075 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% hydrocortisone cream with vasoconstrictor activity
Number of subjects: 0
Study 126075 — intervention group
Group type: COMPARATOR
Intervention: 1.0% Hydrocortisone Cream BPC
Number of subjects: 0